Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology
- PMID: 22105541
- DOI: 10.1007/s00401-011-0913-0
Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology
Abstract
Research into amyotrophic lateral sclerosis (ALS) has been stimulated by a series of genetic and molecular pathology discoveries. The hallmark neuronal cytoplasmic inclusions of sporadic ALS (sALS) predominantly comprise a nuclear RNA processing protein, TDP-43 encoded by the gene TARDBP, a discovery that emerged from high throughput analysis of human brain tissue from patients with frontotemporal dementia (FTD) who share a common molecular pathology with ALS. The link between RNA processing and ALS was further strengthened by the discovery that another genetic locus linking familial ALS (fALS) and FTD was due to mutation of the fused in sarcoma (FUS) gene. Of potentially even greater importance it emerges that TDP-43 accumulation and inclusion formation characterises not only most sALS cases but also those that arise from mutations in several genes including TARDBP (predominantly ALS cases) itself, C9ORF72 (ALS and FTD cases), progranulin (predominantly FTD phenotypes), VAPB (predominantly ALS cases) and in some ALS cases with rare genetic variants of uncertain pathogenicity (CHMP2B). "TDP-proteinopathy" therefore now represents a final common pathology associated with changes in multiple genes and opens the possibility of research by triangulation towards key common upstream molecular events. It also delivers final proof of the hypothesis that ALS and most FTD cases are disorders within a common pathology expressed as a clinico-anatomical spectrum. The emergence of TDP-proteinopathy also confirms the view that glial pathology is a crucial facet in this class of neurodegeneration, adding to the established view of non-nerve cell autonomous degeneration of the motor system from previous research on SOD1 fALS. Future research into the mechanisms of TDP-43 and FUS-related neurodegeneration, taking into account the major component of glial pathology now revealed in those disorders will significantly accelerate new discoveries in this field, including target identification for new therapy.
Similar articles
-
TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.Neuropathology. 2009 Dec;29(6):672-83. doi: 10.1111/j.1440-1789.2009.01029.x. Epub 2009 Jun 3. Neuropathology. 2009. PMID: 19496940
-
FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis.Ann Neurol. 2010 Jun;67(6):739-48. doi: 10.1002/ana.22051. Ann Neurol. 2010. PMID: 20517935 Free PMC article.
-
Molecular basis of ALS and FTD: implications for translational studies.Arh Hig Rada Toksikol. 2015 Dec;66(4):285-90. doi: 10.1515/aiht-2015-66-2679. Arh Hig Rada Toksikol. 2015. PMID: 26751860 Review.
-
Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis.Mol Neurodegener. 2012 Oct 10;7:53. doi: 10.1186/1750-1326-7-53. Mol Neurodegener. 2012. PMID: 23046583 Free PMC article.
-
Molecular basis of amyotrophic lateral sclerosis.Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):370-2. doi: 10.1016/j.pnpbp.2010.07.017. Epub 2010 Jul 23. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 20655970 Review.
Cited by
-
Endothelial TDP-43 controls sprouting angiogenesis and vascular barrier integrity, and its deletion triggers neuroinflammation.JCI Insight. 2024 Feb 1;9(5):e177819. doi: 10.1172/jci.insight.177819. JCI Insight. 2024. PMID: 38300714 Free PMC article.
-
Liquid Biopsy in Neurological Diseases.Cells. 2023 Jul 22;12(14):1911. doi: 10.3390/cells12141911. Cells. 2023. PMID: 37508574 Free PMC article. Review.
-
Insights into the pathological basis of dementia from population-based neuropathology studies.Neuropathol Appl Neurobiol. 2023 Aug;49(4):e12923. doi: 10.1111/nan.12923. Neuropathol Appl Neurobiol. 2023. PMID: 37462105 Free PMC article. Review.
-
The Role of Epigenetics in Neuroinflammatory-Driven Diseases.Int J Mol Sci. 2022 Dec 2;23(23):15218. doi: 10.3390/ijms232315218. Int J Mol Sci. 2022. PMID: 36499544 Free PMC article. Review.
-
Stage-specific control of oligodendrocyte survival and morphogenesis by TDP-43.Elife. 2022 Mar 21;11:e75230. doi: 10.7554/eLife.75230. Elife. 2022. PMID: 35311646 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous